한빛사논문
- 조회3,960
Abstract
From the National Research Laboratory for Cardiovascular Stem Cell (M.-S.K., C.-S.L., J.-H., H.-J.C., S.-I.J., T.-Y.K., S.-W.L., J.-W.S., K.-W.P., H.-Y.L., H.-J.K., H.-S.K.), Innovative Research Institute for Cell Therapy (M.-S.K., C.-S.L., J.-H., H.-J.C., S.-I.J., T.-Y.K., S.-W.L., J.-W.S., K.-W.P., H.-Y.L., H.-J.K., Y.-B.P., H.-S.K.), and Department of Nuclear Medicine (D.-S.L.), Seoul National University Hospital, Seoul, Korea; Biomedical Research Center, Korea Advanced Institute of Science and Technology, Daejeon, Korea (G.-Y.K.); Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Osaka, Japan (H.N., R.M.); and Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea (H.-S.K.).
* To whom correspondence should be addressed.
Background-The low engraftment rate of stem/progenitor cells infused via the intracoronary route to the ischemic myocardium is one of the most important factors limiting the efficacy of cell therapy. We investigated the concept of priming peripheral blood stem cells enriched by granulocyte colony-stimulating factor mobilization and apheresis (mobPBSCs) with angiopoietin-1 (Ang1), to enhance the engraftment into the ischemic tissue and neovasculogenic potential.
Methods and Results-The expression of Tie2, the Ang1 receptor, was significantly higher in mobPBSCs than naive peripheral blood mononuclear cells (19.2±3.0% versus 1.2±0.8% versus 1.2±0.2%; P<0.001 for mobPBSCs from acute myocardial infarction (AMI) patients with granulocyte colony-stimulating factor treatment for 3 days versus peripheral blood mononuclear cells from AMI patients versus peripheral blood mononuclear cells from stable angina patients). After 4 hours of cartilage oligomeric matrix protein (COMP)-Ang1 stimulation, mobPBSCs committed to the endothelial lineage with the induction of CD31 and VE-cadherin expression, mediated by Tie2/Ets-1 pathway. Priming of mobPBSCs with COMP-Ang1 induced the expression of α4β1 and α5β1 integrins, which are also Ets-1 downstream molecules, leading to enhanced adhesion to endothelial cells or fibronectin. In a rabbit ear ischemia/reperfusion model, priming of mobPBSCs with COMP-Ang1 improved first-pass engraftment to the distal vascular bed after intraarterial delivery. In a murine ischemic hind-limb model, intravascular delivery of primed mobPBSCs enhanced both engraftment and neovascularization.
Conclusions-The short-term priming with COMP-Ang1 may be a feasible and promising option to activate mobPBSCs by enhancing differentiation and adhesiveness and to improve the efficacy of cell therapy for ischemic diseases.
Key words: angiogenesis, cell adhesion molecules, growth substances, ischemia, myocardial infarction논문정보
- Research article
- 2009년 11월 (BRIC 등록일 )
- 국내(교신)+국외 연구진
- 의약학 > 응용의학
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
